{"prompt": "['SAR439774 (formerly ALN-AT3SC) (fitusiran)', 'Clinical Study Protocol ALN-AT3SC-004', '(Sanofi Genzyme EFC14769)', '27 Jun 2018', '10.', 'LIST OF REFERENCES', '1. WFH. What is Hemophilia? World Federation of Hemophilia. 2004.', '2. Bauer KA. Current challenges in the management of hemophilia. Am J Manag Care. 2015', 'Mar;21(6 Suppl):S112-22.', '3. Sehgal A, Barros S, Ivanciu L, Cooley B, Qin J, Racie T, et al. An RNAi therapeutic', 'targeting antithrombin to rebalance the coagulation system and promote hemostasis in', 'hemophilia. Nat Med. 2015 May;21(5):492-7.', '4. Schrijvers L, Beijlevelt-Van der Zande M, Peters M, Lock J, Cnossen M, Schuurmans M, et', 'al. Achieving self-management of prophylactic treatment in adolescents: The case of', 'haemophilia. Patient Educ Couns. 2016 Jan 25.', '5. Makris M, Kasper C. The World Federation of Hemophilia guideline on management of', 'haemophilia. Haemophilia. 2013 Jan; 19(1): 1.', '6.', 'Witkop M, Guelcher C, Forsyth A, Hawk S, Curtis R, Kelley L, et al. Treatment outcomes,', 'quality of life, and impact of hemophilia on young adults (aged 18-30 years) with hemophilia.', 'Am J Hematol. 2015 Dec;90 Suppl 2:S3-10.', '7.', 'Saposnik G, Barinagarrementeria F, Brown RD, Jr., Bushnell CD, Cucchiara B, Cushman M,', 'et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare', 'professionals from the American Heart Association/American Stroke Association. Stroke. 2011', 'Apr;42(4):1158-92.', '8. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis', 'Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive', 'Care Med. 2017 Mar;43(3):304-77', '9. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of', 'disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J', 'Haematol. 2009 Apr;145(1):24-33.', '10. Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A.', 'Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014', 'Nov;12(11):1935-9.', '11. Wyrwich KW, Krishnan S, Poon JL, Auguste P, von Maltzahn R, Yu R, et al. Interpreting', 'important health-related quality of life change using the Haem-A-QoL. Haemophilia. 2015', 'Sep;21(5):578-84.', '12. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, et al. Validation of a', 'general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for', 'Medication (TSQM), using a national panel study of chronic disease. Health Qual Life', 'Outcomes. 2004 Feb 26;2:12.', '13. van Genderen FR, Westers P, Heijnen L, de Kleijn P, van den Berg HM, Helders PJ, et al.', \"Measuring patients' perceptions on their functional abilities: validation of the Haemophilia\", 'Activities List. Haemophilia. 2006 Jan; 12(1) 36-46.', 'Property of the Sanofi Group - strictly confidential', '74', '(electronic 1.0)']['SAR439774 (formerly ALN-AT3SC) (fitusiran)', 'Clinical Study Protocol ALN-AT3SC-004', '(Sanofi Genzyme EFC14769)', '27 Jun 2018', '14. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and', 'preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011', 'Dec;20(10):1727-36.', '15. Feldman BM, Funk SM, Bergstrom BM, Zourikian N, Hilliard P, van der Net J, et al.', 'Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis', 'Study Group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken). 2011', 'Feb;63(2):223-30.', 'Property of the Sanofi Group - strictly confidential', '75', '(electronic 1.0)']\n\n###\n\n", "completion": "END"}